Geode Capital Management
RANI icon

Geode Capital Management’s Rani Therapeutics RANI Stock Holding History

Geode Capital Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$678K Sell
890,618
-12,680
-1% -$11.2K ﹤0.01% 3487
2026
Q1 		$664K Buy
903,298
+42,357
+5% +$54.1K ﹤0.01% 3482
2025
Q4 		$1.16M Buy
860,941
+564,031
+190% +$851K ﹤0.01% 3327
2025
Q3 		$148K Buy
296,910
+106,353
+56% +$55.4K ﹤0.01% 4021
2025
Q2 		$97.9K Sell
190,557
-5,660
-3% -$4.62K ﹤0.01% 4067
2025
Q1 		$247K Buy
196,217
+24,644
+14% +$36.5K ﹤0.01% 3776
2024
Q4 		$235K Sell
171,573
-688
-0.4% -$1.45K ﹤0.01% 3852
2024
Q3 		$372K Buy
172,261
+21,527
+14% +$61.7K ﹤0.01% 3697
2024
Q2 		$573K Buy
150,734
+19,828
+15% +$103K ﹤0.01% 3519
2024
Q1 		$407K Buy
130,906
+17,277
+15% +$59.4K ﹤0.01% 3686
2023
Q4 		$377K Hold
113,629
– – ﹤0.01% 3720
2023
Q3 		$247K Buy
113,629
+16,444
+17% +$62.8K ﹤0.01% 3897
2023
Q2 		$400K Hold
97,185
– – ﹤0.01% 3734
2023
Q1 		$501K Hold
97,185
– – ﹤0.01% 3649
2022
Q4 		$573K Buy
97,185
+2,653
+3% +$19.4K ﹤0.01% 3602
2022
Q3 		$905K Buy
94,532
+21,083
+29% +$223K ﹤0.01% 3438
2022
Q2 		$758K Buy
73,449
+2,183
+3% +$25.1K ﹤0.01% 3541
2022
Q1 		$962K Buy
71,266
+8,049
+13% +$134K ﹤0.01% 3634
2021
Q4 		$1.03M Buy
63,217
+41,578
+192% +$945K ﹤0.01% 3705
2021
Q3 		$385K Buy
+21,639
New +$374K ﹤0.01% 4151

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management's RANI Position: Q2 2026 in Review

Geode Capital Management reduced its Rani Therapeutics (RANI) stake by 1.4% in Q2 2026, selling an estimated $11.2K and leaving 890,618 shares worth $678K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Geode Capital Management first reported a position in RANI in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.16M in Q4 2025. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Geode Capital Management held 890,618 shares of Rani Therapeutics worth $678K as of Q2 2026.
  • Geode Capital Management sold 12,680 Rani Therapeutics shares in Q2 2026, an estimated $11.2K.
  • Rani Therapeutics made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3487 holding.
  • Geode Capital Management first reported a position in Rani Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Rani Therapeutics position peaked at $1.16M in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.